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1682-606X/Copyright ª 2015, TaiwanSummary Background/Introduction: Some reports suggest early cholecystectomy for dia-
betic patients with asymptomatic gallstone disease (GSD) to prevent subsequent serious infec-
tion. However, only a few studies have examined the incidence of cholecystectomy in response
to GSD in diabetic patients. Our study attempts to elucidate the relationship between GSD and
diabetes using the high coverage rate health insurance system of Taiwan and thus evaluate the
validity of early cholecystectomy in diabetic patients.
Purpose(s)/Aim(s): To investigate the rate of cholecystectomy in diabetic patients with GSD.
Methods: Diabetic patients without prior treatment for GSD on hospitalization or ambulatory
visits were identified and compared with age- and sex-matched controls and were followed
up for 8 years. Cholecystectomy incidence density rates were estimated according to the pa-
tients’ diabetic status. Cox proportional hazards regression models were used to analyze the
age- and sex-specific effects of diabetes on the risk of surgery for GSD.
Results: The incidence rates of patients who developed GSD and underwent cholecystectomy
were 18.65% and 17.15% in the diabetic and control groups, respectively; thus, the rate of cho-
lecystectomy was higher in the diabetic group than in the control group. Male sex and old age
were associated with a high rate of cholecystectomy, irrespective of the diabetic status. Hy-
pertension, cholangitis, and Caroli disease were associated with an increased risk of cholecys-
tectomy in patients with GSD. Overall, diabetic patients exhibited a higher incidence of
cholecystectomy than nondiabetic patients did over an 8-year follow-up period.ave no conflicts of interest to declare.
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158 C.-M. Liu et al.Conclusion: Men with GSD are more likely to undergo cholecystectomy than women, irrespec-
tive of the diabetic status; therefore, an aggressive GSD management approach for men must
be considered for early identification of these patients before the need for emergency surgery.
Copyright ª 2015, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Gallstone disease (GSD) is a prevalent medical condition
causing considerable economic and social burdens. Epide-
miological evidence indicates that the prevalence of GSD
ranges from 10% to 15%.1 Major risk factors for GSD are old
age, obesity, and female sex. Other factors associated with
an increased risk of GSD are ethnicity, a high-fat or high-
carbohydrate diet, estrogen use, and Gilbert’s syndrome.
By contrast, alcohol and coffee consumption,1 a high-fiber
diet, and statin use seem to lower the risk of GSD.
Furthermore, studies have reported a higher hospital
admission rate among the diabetic population. The esti-
mated age-standardized hospital admission rate for GSD
was 0.6 per 1000 persons.2 However, since the 1990s, an
increasing trend has been observed in the hospital admis-
sion rates for gallstones, which is probably caused in part by
the use of improved technology, notably the use of lapa-
roscopic cholecystectomy (LC) as a treatment option.
Approximately 70e80% of all types of cholecystectomy in
western countries are the LC type. Few studies have eval-
uated the outcome of LC in diabetic patients or the effect
of diabetes-associated comorbidities on the surgical risk in
these patients. Some studies have reported that diabetes
predisposes patients to a high risk of conversion from LC to
open cholecystectomy.
3Evidence reveals thatdiabetes is a risk factor forGSD,and
the prevalence of GSD is higher in diabetic patients than in
nondiabetic patients. In clinical settings, cholecystectomy-
related decisions regarding patients diagnosed with diabetes
remain controversial, particularly in patients with asymp-
tomatic GSD.3 Several studies have suggested that more
attention should be paid to operative and postoperative
complications, GSD-associated morbidities, or both of these
factors in diabetic patients, resulting in superiormanagement
and favorable outcomes in these patients.4 Currently, little is
known about the rate of cholecystectomy for GSD in diabetic
patients compared with that in nondiabetic patients in the
general population. An understanding of this situation in the
general population may enable public health authorities to
provide appropriate health care services and resources in a
cost-effective manner.
Therefore, in the present study, we evaluated and
compared the incidence of cholecystectomy in diabetic and
nondiabetic patients with GSD.
2. Materials and methods
2.1. Data source
The Taiwan Department of Health incorporated health in-
surance programs into the Taiwan National Health Insurance(NHI) system in 1995, and the Bureau of NHI (BNHI) is con-
tracted with 97% of hospitals as well as 90% of clinics in
Taiwan. This retrospective and population-based study was
conducted using data from the BNHI and National Health
Research Institutes (NHRI) databases through data mining.
The BNHI is the NHRI provider of Taiwan and covers
approximately 98e99% of its 23 million residents. To assess
the accuracy of the claims data, the BNHI performs expert
quarterly reviews on a random sample of every 50e100
ambulatory and inpatient claims at each hospital and clinic
and imposes severe penalties on health care providers in
cases of false diagnostic reports. We analyzed the ambula-
tory care and inpatient claims data between 2000 and 2008
of the BNHI as well as obtained an updated registry of ben-
eficiaries. All of the NHI datasets can be interlinked using
individual personal identification numbers.
2.2. Study cohorts and comorbidities
Patients were identified on the basis of the International
Classification of Diseases, Ninth Revision, Clinical Modifi-
cation (ICD-9-CM) diagnostic codes in the ambulatory care
claims records. Patients who received a diabetes-related
diagnosis (ICD-9-CM 250) were selected for the diabetic
group. A person was classified as diabetic if they had
received an initial diabetes-related diagnosis at any time in
the year 2000 and received subsequent diagnoses (one or
more) within 12 months. The first and last outpatient visits
within 1 year were more than 30 days apart to avoid the
accidental inclusion of miscoded patients. To detect newly
diagnosed GSD cases, patients who sought treatment at a
hospital or an ambulatory care facility for gallstones (ICD-9-
CM 574) between 1997 and 1999 were excluded from our
diabetic group. We identified and enrolled 60,734 patients
diagnosed with diabetes in 2000.
Control group participants were selected from the list of
beneficiaries in 2000 and evaluated to ensure that they
were free of diabetes and GSD between 1997 and 2000. The
control group comprised 48,116 randomly selected in-
dividuals who were age- and sex-matched with the patients
in the diabetic group. Cholecystectomy procedures per-
formed between 2000 and 2008 were considered GSD
events.
Furthermore, we searched the ambulatory care visit and
hospitalization claims information for selected specific
comorbidities of hypertension (ICD-9-CM 401, 405), gout
(ICD-9-CM 274), hyperlipidemia (ICD-9-CM 272.0e272.9),
cystic fibrosis (ICD-9-CM 277.0), sickle-cell disease (ICD-9-
CM 282.6), cirrhosis (ICD-9-CM 571.2, 571.5, 571.6), chol-
angitis (ICD-9-CM 576.1), Caroli disease (ICD-9-CM 576.2),
Crohn disease (ICD-9-CM 555.9), and hemolytic anemia
(ICD-9-CM 282, 283). The comorbidities were included only
when the index date during the study period (2000e2008)
Table 1 Baseline characteristics of gallstone disease (GSD)






n % n %
Age (y)
<45 2759 5.7 4262 7.0
45e64 21780 45.3 28,559 47.0
>64 23,577 49.0 27,913 46.0
Mean  SD
age a
62.9  11.1 62.1  11.3
Sex
Male 20,892 43.4 27,145 44.7
Female 27,224 56.6 33,572 55.3
Insurance premium (NTD)
Dependent 13,658 28.4 17,781 29.3
< Median
(16,500)
9069 18.9 11,762 19.4
 Median 25,389 52.8 31,191 51.4
Mean  SD
premium
19,183.1  15,068.0 18,613.6  14,299.0
Charlson’s Comorbidity Index score
0 41,999 87.3 0 0.0
1 4793 10.0 43,389 71.4
2 1324 2.7 17345 28.6
Mean  SD
score
0.2  0.5 1.4  0.8
Geographic area
Northern 21,487 45.1 27,117 45.1
Central 11,705 24.6 13,825 23.1
Southern 13,177 27.7 17,673 29.4
Eastern 1227 2.6 1453 2.4
Urbanization status
Metropolis 19,531 40.9 25,679 42.7
Satellite
city/town
12,576 26.4 15,490 25.7
Rural area 15,611 32.7 19,004 31.6
Total 48,116 100.0 60,734 100.0
NTDZ New Taiwan Dollars; SD Z standard deviation.
a Inconsistency between the total population and the pop-
ulations summed for individual variables is the result of missing
information.
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censoring.
Patients from the diabetic (n Z 11,326) and control
(n Z 8252) groups who had undergone open cholecystec-
tomy (ICD operation 51.22) or LC (ICD operation 51.23)
were linked to the inpatient claims between 2000 and 2008
to identify the surgeries to remove gallstones.
2.3. Statistical analysis
The sociodemographic variables used in this study were
age, sex, occupation, monthly income, and urbanization of
the residential area, and these were compared between
the diabetic and nondiabetic patients with GSD. To inves-
tigate the relationships between variables, univariate and
multivariate Cox proportional hazards regression analyses
were performed, and these relationships were indicated
using adjusted hazard ratios (aHRs) and 95% confidence
intervals (95% CIs) for cholecystectomy between the two
groups. All analyses were performed using SAS Version 9.1
for Windows (SAS Institute, Inc., Cary, NC, USA). A two-
tailed value of p < 0.05 was considered statistically
significant.
3. Results
We recruited 60,734 patients with diabetes without prior
GSD and 48,116 nondiabetic persons without prior GSD in
2000 from the NHRI datasets in this study (Table 1). The
mean  standard deviation ages were 62.9  11.1 and
62.1  11.3 years for nondiabetic controls and diabetic
patients, respectively. Age and sex distributions between
the diabetic and control groups were similar, with women
accounting for 56.6% of the nondiabetic controls and 55.3%
of diabetic patients. In both groups, approximately 50% of
participants were aged >64 years, and 45% were aged be-
tween 45 and 64 years. Diabetic patients had a slightly
lower, but not significantly lower, mean insurance premium
than the nondiabetic controls did. The mean preoperative
Charlson’s Comorbidity Index score was substantially higher
for diabetic patients than for nondiabetic controls
(1.4  0.8 vs. 0.2  0.5, respectively). Urbanization was
prominent in both groups regarding the geographical area,
and the geographical distributions between the two groups
were similar.
Of the diabetic patients and nondiabetic controls iden-
tified in 2000, those who developed symptomatic GSD and
underwent cholecystectomy in 2008 are listed in Table 2.
The overall age- and sex-specific incidence density (ID)
rates of cholecystectomy in the diabetic patients were
higher than those in the nondiabetic controls (45.08 vs.
40.12 per 1000 personeyears, respectively). Of the 60,734
and 48,116 patients in the diabetic and control groups,
11,326 and 8252, respectively, developed GSD and under-
went cholecystectomy, with corresponding incidence rates
of 18.65% and 17.15%, respectively. Irrespective of the
diabetic status, a sex-stratified analysis revealed that men
had a higher ID rate of cholecystectomy than women (dia-
betic men/women: 48.97/42.08 per 1000 patienteyears
and control men/women: 42.87/38.12 per 1000 patiente
years), and this trend was similar among all age groups. Inaddition, the ID rates of cholecystectomy were significantly
associated with old age irrespective of the diabetic status
and sex (Table 2).
During the 8-year follow-up period, diabetic patients
with GSD had higher unadjusted and adjusted incidences of
cholecystectomy than those without GSD did (Table 3).
Diabetic patients with GSD were associated with an 11%
higher incidence of cholecystectomy in a sociodemographic
factor-adjusted analysis than those without GSD
(p Z 0.001). In addition, the risk of GSD and subsequent
cholecystectomy was higher in patients with hypertension
(aHR, 1.12; 95% CI, 1.07e1.16; p < 0.001), cholangitis (aHR,
2.85; 95% CI, 2.75e2.96; p < 0.001), and Caroli disease
(aHR, 1.21; 95% CI, 1.11e1.32; p < 0.001) compared with
Table 2 Overall, age-, and sex-specific incidence densities (IDs) for cholecystectomy in gallstone disease (GSD) patients with
and without diabetes between 2000 and 2008 in Taiwan.











ID (per 1000 patientey)
(95% CI) b
Men (age, y)
<45 1467 179 28.19 (28.18e28.19) 2360 354 34.56 (34.55e34.56)
45e64 9184 1570 39.51 (39.50e39.51) 12,561 2465 46.64 (46.64e46.65)
>64 10,241 1959 48.50 (48.49e48.50) 12,224 2536 54.82 (54.81e54.82)
Total 20,892 3708 42.87 (42.87e42.88) 27,145 5355 48.97 (48.97e48.98)
Women (age, y)
<45 1292 177 31.28 (31.27e31.28) 1898 291 34.15 (34.14e34.15)
45e64 12,596 2139 36.99 (36.98e36.99) 15,989 2927 41.15 (41.15e41.16)
>64 13,336 2228 39.98 (39.98e39.99) 15,685 2750 44.22 (44.22e44.23)
Total 27,224 4544 38.12 (38.11e38.12) 33,572 5968 42.08 (42.07e42.08)
Overall 48,116 8252 (17.15%) 40.12 (40.11e40.12) 60,734 11,326 (18.65%) 45.08 (45.08e45.09)
CI Z confidence interval.
a Inconsistency between the total population and the populations summed for individual variables is the result of missing information.
b Based on the Poisson assumption.
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variate analysis. By contrast, other comorbidities, such as
gout (aHR, 0.96; 95% CI, 0.93e0.99; p Z 0.05), hyperlip-
idemia (aHR, 0.93; 95% CI, 0.91e0.96; p < 0.001), and
cirrhosis (aHR, 1.21; 95% CI, 1.11e1.32; p < 0.001) were
associated with a reduced risk of cholecystectomy. The risk
of GSD and subsequent cholecystectomy was unaffected by
the presence of cystic fibrosis, Crohn disease, and hemo-
lytic anemia.4. Discussion
This study provides epidemiological evidence of the inci-
dence of cholecystectomy in the general population of
Taiwan. Diabetic patients with GSD had a higher incidence
of cholecystectomy than the nondiabetic controls. Men
diagnosed with GSD were more likely to undergo chole-
cystectomy than women in both the diabetic and nondia-
betic groups. In addition, the overall incidence of
cholecystectomy was associated with increasing age, irre-
spective of the diabetic status and sex.
An increasing number of studies on animals and humans
suggest that insulin resistance and diabetes are associated
with organ dysfunction. A combination of diabetes and GSD
is a severe condition that requires special care. The path-
ophysiological features of gallstone formation in patients
with diabetes are unclear. Diabetic patients exhibit an
increased cholesterol index and reduced gallbladder
motility5 compared with nondiabetic individuals. Further-
more, hyperinsulinemia is associated with an increased
prevalence of GSD.6 Insulin resistance and elevated fasting
glucose levels have been associated with gallbladder dys-
motility in nondiabetic people, possibly resulting in acal-
culous cholecystitis or gallstone formation. Consequently,
some reports have recommended early cholecystectomy for
diabetic patients with asymptomatic gallstones to prevent
subsequent serious infection. A large observational studyconcluded that a mere diagnosis of diabetes is not associ-
ated with an increased risk of cholecystectomy. By
comparing the risks associated with diabetes duration,
serum HbA1c levels, and antidiabetic therapy between
diabetic patients and controls, the investigators reported
that diabetes was not an independent risk factor for
cholecystectomy.7
Diabetes and male sex are known risk factors for acute
cholecystitis and, in general, cholecystitis is more severe in
men than in women, even though the cause of severe
cholecystitis remains unknown for a high proportion of
men. In a previous study comprising 500 patients who had
undergone cholecystectomy, 76% of the patients were
women2; however, within the acute cholecystitis subset,
only 57% of the patients were women. Some reports have
indicated that acute cholecystitis is often more fulminant
in men than in women, and the higher mortality rate in men
than in women may reflect the unwillingness of men to seek
medical attention until the disease is at an advanced stage.
A recent study reported that men have a higher percentage
and conversion rate of acute cholecystitis than women do
because of inflammation or bacterial adherence.8 Women
usually exhibit a greater willingness to seek medical
attention for mild biliary symptoms than men. Landau et al3
stated that the higher pain threshold in men compared with
women results from delayed presentation at an advanced
stage of the disease, and the delay may be caused by
psychological and social factors. This finding was further
supported by results regarding inflammation and fibrosis in
patients with acute cholecystitis, which is more severe in
men than in women. Whether the sex-based differences are
biological, behavioral, or both, the implications for patient
management should be self-evident. An aggressive GSD
management approach for men and timely intervention
before the need for emergency surgery are recommended.
Additional studies are required for further investigation of
these differences, which can increase the awareness of the
GSD-associated problems and their occurrence in men.
Table 3 Relative hazards for cholecystectomy in relation to diabetes and other selected comorbidities between 2000 and 2008
in Taiwan.
Variables No. of GSD patients Cholecystectomy a Hazard ratio estimate
n % HR 95% CI b p aHR c 95% CI b P
Diabetes
No 48,116 8252 17.2 1.00 1.00
Yes 60,734 11,326 18.7 1.10* 1.07e1.14 < 0.001 1.11* 1.04e1.18 0.001
Hypertension
No 21,371 3464 16.2 1.00 1.00
Yes 87,479 16,114 18.4 1.18* 1.14e1.22 < 0.001 1.12* 1.07e1.16 < 0.001
Gout
No 74,631 13,556 18.2 1.00 1.00
Yes 34,219 6022 17.6 0.97 0.94e1.00 0.052 0.96* 0.93e0.99 0.005
Hyperlipidemia
No 42,189 7709 18.3 1.00 1.00
Yes 66,661 11,869 17.8 0.97* 0.94e0.99 0.019 0.93* 0.91e0.96 < 0.001
Cystic fibrosis
No 108,844 19,577 18.0 1.00 1.00
Yes 6 1 16.7 0.93 0.13e6.61 0.945 1.14 0.16e8.08 0.898
Cirrhosis
No 97,531 17,703 18.2 1.00 1.00
Yes 11,319 1875 16.6 0.95* 0.90e0.99 0.022 0.88* 0.84e0.93 < 0.001
Cholangitis
No 98,903 15,532 15.7 1.00 1.00
Yes 9947 4046 40.7 2.92* 2.82e3.03 < 0.001 2.85* 2.75e2.96 < 0.001
Caroli disease
No 107,225 19,015 17.3 1.00 1.00
Yes 1625 563 34.7 2.18* 2.01e2.38 < 0.001 1.21* 1.11e1.32 < 0.001
Crohn disease
No 103,760 18,678 18.0 1.00 1.00
Yes 5090 900 17.7 0.99 0.92e1.06 0.699 0.98 0.92e1.05 0.606
Hemolytic anemia
No 108,124 19,439 18.0 1.00 1.00
Yes 726 139 19.2 1.08 0.91e1.28 0.374 1.06 0.90e1.26 0.479
Total 108,850 19,578 18.9
*p < 0.05.
aHR Z adjusted hazard ratio; CI Z confidence interval; HR Z hazard ratio.
a Gallstone-related operations including cholecystectomy (ICD-9:51.22) and laparoscopic cholecystectomy (ICD-9:51.23).
b Based on the Poisson assumption.
c Based on Cox proportional hazards regression with adjustment for age, sex, insurance premium, Charlson’s Comorbidity Index score,
geographic area, urbanization and diabetes status, hypertension, gout, hyperlipidemia, cystic fibrosis, cirrhosis, cholangitis, Caroli
disease, Crohn disease, and hemolytic anemia.
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health policies for men with GSD and provide favorable
diabetes- and GSD-related management approaches for
health policy makers and clinicians.
The higher rate of GSD-related surgery in the diabetic
group compared with the control group may indicate a
different presentation of pain symptoms between the two
groups, which might be explained by diabetic neuropathy.9
Diabetic rats exhibited sluggish sensory nerve conduction
and a high pain threshold.10 Evidence has indicated that
hyperglycemia may result in changes to the gastric motor
and sensory functions, suggesting that any impaired sensory
functioning might be related to the dysfunctional control of
blood glucose in diabetic patients. Therefore, diabetic
patients are likely to be less sensitive to their pain symp-
toms, and this seems to delay GSD diagnosis until acute andsevere cholecystitis develops. This eventually leads to a
higher incidence of cholecystectomy in diabetic patients
than in nondiabetic controls.5. Conclusion
To our knowledge, this is one of the few studies to
examine the incidence of cholecystectomy in response to
GSD in diabetic patients by using a nationwide population-
based cohort study design. Given the high coverage rate of
the NHI system in Taiwan, the likelihood of nonresponse
and loss to follow-up are extremely low, ensuring the
representativeness of the study participants and
the validity of the estimates for the incidence of chole-
cystectomy in response to GSD. In addition, we have
162 C.-M. Liu et al.satisfactorily used the longitudinal design of the NHI
dataset to follow up on the incidence rates of surgery for
GSD in the diabetic and control groups. This study offers a
valuable cross-sectional longitudinal analysis of the pop-
ulation pertaining to GSD and diabetes. Future studies are
required to identify possible mechanisms related to the
association between the presence of diabetes and the
increased use of cholecystectomy in GSD treatment. In
addition to improving the clinical management of dia-
betes, our findings will facilitate the development of
public policies related to health care services and resource
distribution for diabetes and its complications among the
general population.References
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